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ABSTRACT
Toxic and mutagenic O6-alkylguanine adducts in DNA
are repaired by O6-alkylguanine-DNA alkyltrans-
ferases (MGMT) by transfer of the alkyl group to a
cysteine residue in the active site. Comparisons
in silico of prokaryotes and lower eukaryotes reveal
the presence of a group of proteins [alkyltransferase-
like (ATL) proteins] showing amino acid sequence
similarity to MGMT, but where the cysteine at the puta-
tive active site is replaced by tryptophan. To examine
whether ATL proteins play a role in the biological
effects of alkylating agents, we inactivated the
gene, referred to as atl11, in Schizosaccharomyces
pombe, an organism that does not possess a
functional MGMT homologue. The mutants are sub-
stantially more susceptible to the toxic effects of
the methylating agents, N-methyl-N-nitrosourea,
N-methyl-N0nitro-N-nitrosoguanidine and methyl
methanesulfonate and longer chain alkylating
agents including N-ethyl-N-nitrosourea, ethyl methan-
esulfonate, N-propyl-N-nitrosourea and N-butyl-
N-nitrosourea. Purified Atl1 protein does not transfer
methyl groups from O6-methylguanine in [3H]-methy-
lated DNA but reversibly inhibits methyl transfer by
human MGMT. Atl1 binds to short single-stranded
oligonucleotides containing O6-methyl, -benzyl,
-4-bromothenyl or -hydroxyethyl-guanine but does
not remove the alkyl group or base and does not
cleave the oligonucleotide in the region of the
lesion. This suggests that Atl1 acts by binding to
O6-alkylguanine lesions and signalling them for pro-
cessing by other DNA repair pathways. This is the first
report describing an activity that protects S.pombe
against the toxic effects of O6-alkylguanine adducts
and the biological function of a family of proteins that
is widely found in prokaryotes and lower eukaryotes.
INTRODUCTION
A wide variety of DNA repair mechanisms have evolved to
protect cells and organisms against the adverse biological
effects of diverse environmental genotoxic agents (1). Alky-
lating agents generate a number of different base modifications
in DNA, including O6-alkylguanine, which is both toxic and
mutagenic (2–5). Repair of this lesion involves the removal of
the alkyl group from the O6 position of the affected guanine
residue and its transfer to a cysteine residue at the active site of
O6-alkylguanine-DNA alkyltransferase [the human version of
which is MGMT (6–8)]. This reaction, which does not require
any cofactors, reverses the damage and inactivates the protein,
leading to its degradation. The alkyl acceptor cysteine is part
of the motif PCHRI/V that is found in all functional alkyl-
transferase proteins and substitution of this residue inactivates
the protein (7). Alkyltransferase proteins are found in prokary-
otes and eukaryotes and some organisms, such as Escherichia
coli and Caenorhabditis elegans contain two functional genes.
In silico analysis shows the existence of a group of alkyl-
transferase homologues in which the cysteine residue in the
putative active site has been replaced. These proteins have
previously been designated as alkyltransferase-like (ATL)
proteins (9,10). In the Conserved Domain Database (11)
these proteins share a domain designated as COG 3695 (pre-
dicted methylated DNA-protein cysteine methyltransferase),
although COG 3695 also covers sequences with cysteine at the
active site. In the majority of ATL proteins, the active site
cysteine residue has been substituted by trytophan (9). Some
organisms, such as Schizosaccharomyces pombe, contain only
an ATL and no discernible alkyltransferase gene, whilst
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others, such as Saccharomyces cerevisae and most higher
eukaryotes, contain an alkyltransferase gene, but no recogniz-
able ATL gene. E.coli, however, contains not only two alkyl-
transferase proteins, ada (12) and ogt (13) but also an ATL
protein, which is the product of the ybaZ open reading frame.
The function of ATL proteins is unknown and it is also not
clear whether they all have the same function. While the
sequence similarity to alkyltransferase proteins suggests a
role in the repair of potentially lethal alkylation damage, no
reduced toxicity of the alkylating agent, N-methyl-N0-nitro-N-
nitrosoguanidine (MNNG), was seen in E.coli overexpressing
the ybaZ gene product (eATL) (10). Purified eATL was able to
bind to single- and double-stranded oligonucleotides contain-
ing O6-methylguanine (O6-meG) but not other lesions such as
8-oxoguanine, ethenoadenine, 5-hydroxymethylcytosine or
O4-methylthymine. Besides binding to O6-meG containing
DNA, no other activity of eATL was found in that study.
This prompted us to investigate the function of a potential
ATL protein in S.pombe identified through sequence homo-
logy (9,10), and the product of the open reading frame, ORF
SPAC1250.04c, now named atl1+. It was considered that the
absence of a functional alkyltransferase gene may result in
functional differences between ATL proteins in E.coli and
S.pombe. Previous studies of the mechanisms involved in
the protection of S.pombe against the toxic effects of alkylat-
ing agents has concentrated on the response to methyl
methanesulfonate (MMS), a bimolecular nucleophilic sub-
stitution (SN2) alkylating agent whose toxicity is mediated
predominantly by 3-methyladenine-induced strand breaks
(14–17). The mechanisms protecting S.pombe against the
effects of unimolecular nucleophilic substitution (SN1)
alkylating agents such as N-methyl-N-nitrosourea (MNU),
whose toxicity is mediated predominantly by O6-meG, are
relatively unexplored.
We describe here for first time an activity that protects
S.pombe against the toxic effects O6-alkylguanine adducts
in DNA and the biological function of a family of proteins
that is widely found in prokaryotes and lower eukaryotes.
MATERIALS AND METHODS
Deletion of atl1+ in S.pombe
Oligonucleotides were designed to PCR amplify 50 and 30
internal regions of atl1+ and the ura4 cassette. Oligonu-
cleotides PRI43S 50-CGCTCGAGCGATATCTCGCGGATC-
CAATGGC and PRI44AS 50-GCGCTAGCGCTCCACCA-
AGTTGACAAAGTAAG were used to PCR amplify a 50
region of atl1+ spanning bases 1525–2472 of sequence from
accession number AL110509. Oligonucleotides PRI45S
50-CGGCTAGCAAGCCTTAATACGATTACTTAATTGGC
and PRI46AS 50-GCCATATGACCCAGCATCAAACT-
GAGGAGTG were used to PCR amplify a 30 region of
atl1+ spanning bases 2824-3745. The 50 and 30 flanking
PCR products were ligated individually into pGEM-Teasy
and named pGEM-Y1-4 and pGEM-Y2A respectively.
Oligonucleotides PRI43S and PRI46AS contain XhoI and
NdeI restriction sites, respectively. PRI44AS and PRI45S
both contain an NheI restriction site. pGEM-Y2A was digested
with NheI/NdeI and the resultant atl1+ insert was purified
and ligated into NheI/NdeI digested Y1-4 to create
pGEM-Y1-4-Y2A. Oligonucleotides PRI55S 50-GCTAGC-
CGCCAGGGTTTTCCCAGTCACGAC and PRI56AS 50-
GCTAGCAGCGGATAACAATTTCACACAGGA (both of
which contain an NheI site) were used to PCR amplify the
ura4 cassette from pBluescript-KS-URA which was ligated
into pGEM-Teasy to create pGEM-KS-URA4. The ura4 cas-
sette was removed from pGEM-KS-ura4 with NheI and ligated
into NheI digested pGEM-Y1-4-Y2A to make pGEM-Y1-4-
Y2A-KS-ura4. The whole insert was PCR amplified using
PRI43S and PRI46AS and was transformed into wild-type
S.pombe strain GM1 (h+, leu1-32, ura4-D18, his7-366,
ade6-M210) using standard methods (18). Chromosomal
disruption was confirmed by analytical PCR using PRI106S
50-CGATACCGTCGACCTCGAGGG and PRI107AS
50-CTGTTTAGTTTGACTCTGAAGG which bind to the
ura4 cassette and S.pombe genomic DNA, respectively and
sequencing. The absence of functional Atl1 in the deletant was
shown in gel shift experiments using [32P]-labelled oligon-
ucleotides containing a single O6-meG residue (see below).
Agar plate assays
All S.pombe strains were grown and manipulated using stan-
dard conditions and methods (19). Alkylating agents (obtained
from Sigma-Aldrich, Poole, Dorset, UK) were dissolved in dry
dimethylsulphoxide. In order to avoid chemical decom-
position of the agents that may have occurred if they were
added directly to molten agar, aliquots (50 ml) of the diluted
compounds were added to the plates and spread evenly. Within
10 min, 101, 102, 103, 104 and 105 dilutions of S.pombe
were made from a culture containing 1.2 · 107 cells/ml and
5 ml aliquots were spotted immediately onto YES agar plates.
Growth inhibition assays
A liquid culture assay was used to examine the effect of a
series of nitrosoureas and methanesulfonates of increasing
carbon chain length on the growth of wild type and Dat1l
strains. To the outermost wells of a 96-well plate were
added 200 ml of water and to one lane was added 200 ml of
YES (blank). An aliquot (150 ml) of an overnight culture (2 ·
107 cells/ml) of each of WT (h+, leu1-32, ura4-D18, his7-366,
ade6-M210) and Dat1l::ura4+ (h+, leu1-32, ura4-D18,
his7-366, ade6-M210, atl1::ura4+) was then added to 10 ml
of YES and 100 ml aliquots of this was added to the empty
wells. For each agent to be tested, stock solutions in dry
DMSO (40 mg/mL) were serially diluted (1:10) into YES
and 100 uL aliquots added to the wells in triplicate. After
mixing gently by rocking, the plates were left, covered, at
30C for 24 h. The contents of the wells were then resuspended
using a multi-channel pipette and the OD595 was measured
using a plate reader (Tecan, Genios). Results were expressed
as a percentage of the growth of the YES only control. From
these results, a narrower range of concentrations of drugs were
used for more accurate determination of the concentration
required for 50% growth inhibition (IC50) values.
Atl1+ cloning, expression and purification
The atl1+ gene was isolated from S.pombe genomic
DNA, using the primers: 50-GGAATTCATGCGTATGGAC-
GAATTTTATACAAAG and 50 CGGGATCCTTAAGGCTT-
CCACATGTATTCTGG, cloned into pMAL2c, overexpressed
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in E.coli and the protein purified essentially as described
previously (10).
MGMT Competition assays
The effect of preincubation of [3H]-methylated MGMT sub-
strate DNA or short oligonucleotides with ATL proteins on the
transfer of [3H]-methyl groups to human MGMT were deter-
mined in a series of competitive inhibition assays. In all cases,
following incubation with MGMT, excess substrate DNA was
hydrolysed to acid solubility and radioactivity transferred to
protein determined by liquid scintillation counting as
described previously (20).
Methyl transfer to MGMT was determined after preincuba-
tion of the substrate with varying amounts of purified ATL
proteins, then incubation with excess MGMT for 15 min at
37C. Based on this, the kinetics of recovery from ATL inhibi-
tion was determined by incubation with MGMT for varying
times up to 40 min. The highest extent of inhibition was
observed at 2.5 min, and the effect of varying the amounts
of ATL was also assessed using this time interval. The effect of
varying the time of preincubation with 50% inhibiting
amounts of Atl1 for up to 3 h on the inhibition of MGMT
was also assessed.
Oligonucleotides of the sequence 50-AACAGCCATAT-
XGCCC [where X indicates the location of the alkylated
bases: O6-methyl, hydroxyethyl, benzyl or (4-bromothenyl)-
guanine] were synthesized as described by Williams and
Shibata (2005) (21). Oligonucleotides containing O6-benzyl
or (4-bromothenyl)-guanine are potent inactivators of MGMT.
To investigate the effect of Atl1 on the ability of these oligonu-
cleotides to inactivate MGMT, increasing amounts of purified
Atl1 were added to a fixed amount of oligonucleotide that
almost completely inactivated a fixed amount of MGMT.
After incubation at 37C for 15 min MGMT was added and
the incubation continued for 10 min after which substrate
DNA was added and the incubation continued for 10 min.
To examine the thermal stability of the ATL proteins,
dilutions of these and MGMT were placed in a heating
block set at 95C. The temperature of the samples, monitored
in a parallel tube with a thermocouple thermometer,
increased from room temperature to 90C over 1 min and
from 90 to 95C over the next minute. The samples were held
at 95C for 1 min then removed from the block to room
temperature. They cooled to 55C over 2 min and were
then placed in ice. Inhibition of MGMT by the heat-treated
proteins was determined as above in parallel with non-heated
samples.
Oligonucleotide binding assays
Gel shift assays using the above oligonucleotides or
those containing 8-oxoguanine (50-GGACTOCAGCTC-
CGTGGTGGCCCGAATTC; O ¼ modified base),
5-hydroxymethylcytosine (50-CTGGGAHTGCAGCTCCG-
TGGTGGCCCGAATTC, H ¼ modified base) or ethenoade-
nine (50-GGACTGCEGCTCCGTGGTGGCGAATTC, E ¼
modified base) were carried out as described previously
(10). Briefly, oligonucleotides were 50-end labeled using poly-
nucleotide kinase (Roche) and g-[32P]-ATP (6000 Ci/mmol;
Amersham Biosciences) purified by microspin column
chromatography and incubated with crude S.pombe extracts
or purified ATL proteins, then subjected to polyacrylamide gel
electrophoresis and phosphorimager analysis.
Oligonucleotides containing a PstI restriction endonuclease
site that was blocked by the presence of O6-meG (50-GAAC-
TXCAGCTCCGTGCTGGCCC, where X ¼ O6-meG) were
used to investigate possible demethylation by Atl1. These
were 50 end labeled with [32P] as above, hybridized to com-
plement oligonucleotide (C opposite O6-meG), incubated with
Atl1 or MGMT, deproteinized and subjected to PstI digestion
and denaturing polyacrylamide gel electrophoresis as pre-
viously described (10).
RESULTS
Atl1+ deletion in S.pombe sensitizes to alkylating
agent toxicity
Insertional inactivation of the S.pombe atl1+ gene did not
detectably affect morphology, or growth rate in YES, but
did affect the phenotype as shown in the oligonucleotide bind-
ing experiments described below. Incorporation of methylat-
ing agents into the agar onto which aliquots of serial dilutions
of WT or Datl1 strains were spotted resulted in a dose depen-
dent killing that was substantially greater in the atl1 deletant.
The difference was considerably more marked with MNU than
MMS (Figure 1).
To quantify the effects of two series of alkylating agents on
the growth of wild-type and Datl1 strains, and to avoid the
possible problems of incorporation of unstable compounds
into molten agar or spreading them homogeneously onto
agar plates, a microtitre plate liquid assay was used: the results
are shown in Figure 2. Datl1 cells were, to varying extents,
more sensitive to the growth inhibitory effects of all the agents
tested. For the nitrosourea series, the difference decreased in
the order MNU > ENU > PNU > BNU, and for the methane-
sulfonate series it increased, MMS < EMS < PMS. Sensitiza-
tion to N-methyl-N0-nitro-N-nitrosoguanidine (MNNG) was
similar to that seen with MNU. Table 1 summarises the
IC50 values for the agents shown in Figure 2.
Figure 1. Sensitivity of WT andDatl1 S.pombe strains to MMS and MNU in an
agar plate assay. Undiluted (U) or serial 1:10 dilutions of the yeast were spotted
onto agar plates containing the concentrations of MMS or MNU indicated.
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Atl1 inhibits the action of MGMT
Preincubation of [3H]-methylated DNA with increasing
amounts of S.pombe Atl1 protein for 2.5 min (Figure 3A)
at 37C inhibited the transfer of [3H]-methyl groups to
MGMT following its addition and further incubation at
37C for 15 min. The ATL protein from E.coli showed similar
effects. These results indicated that the ATL proteins bind
rapidly to substrate DNA and prevent the action of MGMT.
Using amounts of ATL proteins that caused 80% inhibi-
tion of MGMT in the above assays, varying the length of the
incubation at 37C following addition of MGMT showed that
this inhibition was reversible (Figure 3B). The most extensive
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Figure 2. Effect of increasing concentrations of alkylating agents on the growth of WT (open squares) and Datl1 (filled squares) S.pombe strains. Values are
expressed as a percentage of the growth of vehicle-treated controls.
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inhibition was seen at the shortest incubation times post
MGMT addition and this progressively decreased during
incubation with an initial half life of between 20 and
30 min (Figure 3C). Very similar effects were seen with
both the E.coli and S.pombe ATL proteins. These results
suggest that ATL proteins are not able to demethylate or
depurinate O6-meG, although the possibility of cleavage
outside the region of the lesion cannot be excluded.
Using an amount of Atl1 or eATL that caused 50% inhibi-
tion of MGMT in these assays, varying the time of preincu-
bation with the substrate up to 3 h at 37C had no influence on
inhibition (Figure 4A). Under these conditions, there was also
no apparent transfer of radioactivity to either of the ATL
proteins. These results suggest that the reversibility of
MGMT inhibition by ATL was not due to any time-dependent
decreased binding capacity of the ATL proteins to O6-meG in
substrate DNA, such as might have occurred if the ATL pro-
teins had undergone slow degradation. Furthermore, while
heat treatment (see Materials and Methods) of MGMT resulted
in complete loss of its methyl transfer activity it caused only
40% reduction in the ability of both E.coli and S.pombe ATL
proteins to inhibit MGMT (Figure 4B), again indicating a
relatively high thermal stability of the ATL proteins.
Preincubation of Atl1 with short single-stranded oligonu-
cleotides containing O6-benzyl or O6-[4-bromothenyl]-guanine
reduced their ability to inactivate MGMT (Figure 4C). The
amounts of oligonucleotides used were selected to almost
completely inactivated MGMT. Increasing amounts of
Atl1 progressively inhibited MGMT in the absence of oligonu-
cleotides, but preincubation of the oligonucleotides with these
amounts of Atl1 progressively reduced their ability to inactivate
MGMT. As the amounts of Atl1 increased further, this effect
was lost, presumably because there was sufficient Atl1 to bind to
both the oligonucleotides and the MGMT substrate DNA.
Atl1 binds to short oligonucleotides containing
O6-alkylguanines
Incubation of cell-free extracts of WT S.pombe with [32P]-
lablelled oligonucleotides containing a single O6-meG residue
showed a shifted band that was not present with extracts of
Datl1 (Figure 5A). This phenotypic demonstration of loss of
Atl function correlated with the genotype described above.
The purified S.pombe Atl1 bound to 50-[32P]-labeled short
singlestranded oligonucleotides containing a guanine residue
that was modified at the O6-position with methyl, benzyl,
4-bromothenyl or hydroxyethyl groups. Under the conditions
used, no binding was evident to a non-modified oligonu-
cleotide (Figure 5B).
Denaturing gel electrophoresis showed that [32P]-labelled
oligonucleotides containing a Pst1 recognition site were
extensively cleaved by Pst1 and this was prevented in oligonu-
cleotides containing O6-meG in the recognition sequence.
Incubation of such oligonucleotides with MGMT extensively
demethylated the O6-meG and thus restored Pst1 digestability,
but incubation with Atl1 had no effect (Figure 5C). This is
consistent with the earlier suggestion that Atl1 is not able to
remove methyl groups from O6-meG, although depurination of
this base may also have resulted in lack of Pst1 cleavage in this
assay.
There was no evidence of binding to oligonucleotides con-
taining the modified bases, 8-oxoguanine, 5-hydroxymethyl-
cytosine or ethenoadenine under conditions in which there was
clear binding to an O6-meG-containing oligonucleotide
(Figure 5D). This suggests that Atl1 does not bind to these
other modified bases, although we cannot exclude the possi-
bility that binding may occur under different incubation con-
ditions, or was disrupted during electrophoresis.
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Figure 3. Inhibition of MGMT activity by ATL proteins. (A) effect of increasing amounts of ATL proteins (open squares, Atl1; closed squares, eATL). (B) Effect of
time of incubation following addition of MGMT (triangles, Atl1; squares, eATL; filled circles, MGMT protein alone). (C) Kinetics of loss of MGMT inhibition
(triangles, Atl1; squares, eATL).
Table 1. IC50 values of alkylating agents in WT and Datl1 S.pombe strains
Agent IC50 (mg/ml)
WT Datl1 Ratio
N-methyl-N-nitrosourea (MNU) 48 12 4.0
N-ethyl-N-nitrosourea (ENU) 98 58 1.7
N-propyl-N-nitrosourea (PNU) 200 130 1.5
N-butyl-N-nitrosourea (BNU) 214 184 1.2
N-methyl-N0-nitro-N-nitrosoguanidine (MNNG) 0.60 0.26 2.3
Methyl methanesulfonate (MMS) 70 54 1.3
Ethyl methanesulfonate (ENS) 2.3 1.2 1.8
Propyl methanesulfonate (PMS) 3.1 1.3 2.4
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DISCUSSION
To investigate whether or not Atl1 plays a role in the process-
ing of alkylation damage in DNA in the intact organism, we
generated a deletion mutant of atl1+ by insertional inactivation
using a selectable marker. In comparison with wild type, the
mutants showed increased sensitivity to the growth inhibitory
effects of a number of agents that are known to alkylate the O6-
position of guanine in DNA. The difference was most apparent
with the SN1 methylating agents, MNU and MNNG for
which O6-meG represents 6% of the total DNA methylation
products (3). In the nitrosourea series, the difference tended to
decrease with increasing length of the alkyl group, such that
A B C
-10
0
10
20
30
40
50
60
0 0.5 1 1.5 2 2.5 3
Time (hours)
M
G
M
T
a
ct
iv
ity
(fm
o
le
s)
0
10
20
30
40
50
60
70
0 100 200 300 400
ATL protein (ng)
M
G
M
T
a
ct
iv
ity
(fm
o
le
s)
0
10
20
30
40
50
60
70
0 50 100 150 200
spATL protein (ng)
M
GM
T
a
ct
iv
ity
(fm
o
le
s)
Figure 4. (A) Effect of time of preincubation of ATL proteins with MGMT substrate DNA on MGMT activity (triangles, Atl1; squares, eATL; open symbols, ATL
proteins alone; filled symbols, after addition of MGMT; filled circle, MGMT alone). (B) Effect of heat on ATL activity (triangles, Atl1; squares, eATL; continuous
line, before heating; broken line, after heating; open circle, MGMT activity after heating). (C) Effect of preincubation with Atl1 on the ability of oligonucleotides
containing O6-benzylguanine (filled diamonds) or O6-(4-bromothenyl)guanine (open diamonds) to inactivate MGMT. Inhibition of MGMT by Atl1is indicated by
open triangles.
Figure 5. Non-denaturing PAGE analyses of the effect of crude extracts of S.pombe or purified Atl1 on [32P]-labelled oligonucleotides containing modified bases.
(A) O6-methylguanine-containing oligonucleotides were incubated with crude extracts from wild-type (WT) or Datl1 (D) S.pombe, with purified Atl1 or buffer only
(). Note that the Atl1-fusion protein–oligonucleotide complex runs in a different location to the native protein complex. (B) Control (Con) or O6-methylguanine
(MeG), O6-benzylguanine (BnG), O6-(4-bromothenyl)guanine (4BT) or O6-hydroxyethylguanine (EG)-containing oligonucleotides were incubated with buffer ()
or purified Atl1 (+) as described in Materials and Methods. (C) Control or O6-methylguanine (MeG) containing oligonucleotides were incubated with buffer () or
purified Atl1 or MGMT as indicated, then phenol–chloroform extracted and subjected to digestion with Pst1 as described in Materials and Methods. (D) Control
(Con) or O6-methylguanine (MeG), 8-oxoguanine (oxoG), 5-hydroxymethylcytosine (OHC) or ethenoadenine (EA) containing oligonucleotides were incubated with
purified Atl1 as described in Materials and Methods.
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smaller differences were observed for ENU, PNU and BNU.
For the methanesulfonate series, the smallest difference was
seen with MMS, probably reflecting its character as an SN2-
type electrophile which results in relatively small amounts
(<0.1%) of O6-meG being generated in DNA (3). The increas-
ing differences seen with EMS and PMS may reflect the
increasing SN1-type character of these agents and the genera-
tion of relatively larger amounts of O6-alkylguanine in DNA
(2). It should be noted that both nitrosoureas and methanesul-
fonates generate widely differing amounts of up to 12 different
DNA alkylation products, several of which are known to be
toxic (4,22). This may explain the variable effect of atl1+
deletion. Toxicity may also arise from alkylation of cellular
constituents other than DNA. Nevertheless, these results dem-
onstrate that Atl1 is an important factor in the protection of
S.pombe against the toxic effects of the agents examined.
To investigate the possible mechanism by which Atl1pro-
tects the host against the toxic effects of alkylating agents we
overexpressed the protein in E.coli and investigated its prop-
erties in vitro after purification. After incubation of purified
Atl1with [3H]-MNU methylated DNA, no detectable radioac-
tivity was transferred to the protein This indicated that, using
experimental conditions developed for the assay of MGMT
activity, the S.pombe Atl1 protein does not exhibit methyl-
transferase activity. However, Atl1 strongly inhibited the
action of MGMT on substrate DNA, suggesting that Atl1
binds to DNA containing O6-meG. Given the active site homo-
logy, it seems likely that this binding is directly to the O6-meG
residues. Inhibition of MGMT was rapid, but reversible, dem-
onstrating that Atl1 was not capable of removing the
O6-methyl groups or changing the substrate in a way that
completely prevented the action of MGMT. This precludes
extensive removal of the base by a glycosylase activity.
Prolonged preincubation of Atl1 with substrate DNA showed
that the interaction was stable at 37C. Indeed, heat treatment
of Atl1 resulted in only partial loss of the MGMT inhibitory
activity, indicating that the protein is quite resistant to thermal
inactivation. Very similar results were obtained with the E.coli
homologue with which Atl1 has 33% sequence similarity
(9,10). Further support of the suggestion that Atl1 does not
demethylate O6-meG was provided by the observation that
while Atl1 bound to double-stranded oligonucleotides contain-
ing this base in a Pst1 recognition sequence, this did not result
in the restoration of the ability of Pst1 to cleave at this site. In
these experiments there was also no evidence of cleavage at
the position of the O6-meG residue in the oligonucleotide,
suggesting that no glycosylase/AP lyase or endonuclease
activity, operating in the vicinity of the alkylated residue
was associated with Atl1.
We exploited the ability of Atl1 to bind to O6-meG and
inhibit MGMT to investigate the range of lesions recognized
by the protein. The competitive inhibition and gel-shift assays
show that Atl1 can bind to oligonucleotides containing gua-
nine residues modified with a range of O6-substituents. The
overlap between the lesions recognized by Atl1 and MGMT
may explain why some organisms are able to dispense with
one of these genes. Of note is that Atl1 bound effectively to
oligonucleotides containing hydroxyethylguanine, a lesion
that is not effectively processed by human MGMT (23).
This may explain the presence of an ATL alongside two alkyl-
transferase genes in some organisms such as E.coli. Given the
differences between the Human and E.coli MGMT proteins in
processing guanine residues with large O6-alkyl adducts and
that ATL has a tryptophan residue in place of a cysteine res-
idue, examination of the MGMT structures may allow specu-
lation on the critical residues in the binding pocket.
Our results suggest that Atl1 is a damage recognition factor
that licenses a range of O6-alkylguanine lesions in DNA for
processing and elimination. Atl1 might thus, for example, act
in a similar fashion to the damage sensing heterodimer in
higher eukaryotes, XPC-hHR23B (24). In this case it might
be expected to signal to the downstream components of nuc-
leotide excision repair. However, alternative possibilities not
involving lesion removal, such as damage tolerance or lesion
replicative by-pass (25) cannot be excluded.
There is evidence that nucleotide excision repair is involved
in the processing of longer chain alkylguanines in DNA in
mammalian cells (26–28) however, the proteins that recognize
these lesions have not been identified. S.pombe Atl1 would be
a candidate for such a protein, but we have been unable to find
ATL homologues in higher eukaryotes by searching for
sequence similarity. This does not exclude the possibility of
functional homologues and given the broad substrate specifi-
city of the S.pombe Atl1 protein, such a homologue in man
would have important implications in studies of human dis-
eases including cancer and its treatment.
In conclusion, we have identified a protein that protects
S.pombe against the toxic effects of a wide range of O6-
alkylguanine adducts in DNA. It is the first report of such
an activity in S.pombe as well as the first report on the bio-
logical activity of a family of proteins that is widely found in
prokaryotes and lower eukaryotes.
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